Makoto Ota
Gründer bei WELBE, INC.
Vermögen: 38 Mio $ am 30.04.2024
Aktive Positionen von Makoto Ota
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| WELBE, INC. | Direktor/Vorstandsmitglied | 01.12.2011 | - |
| Gründer | 01.12.2011 | - | |
| Präsident | 01.12.2011 | - | |
| Welbe Healthcare, Inc. | Direktor/Vorstandsmitglied | 01.06.2021 | - |
Karriereverlauf von Makoto Ota
Ehemalige bekannte Positionen von Makoto Ota
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TELLA, INC. | Direktor/Vorstandsmitglied | 01.11.2004 | - |
Statistik
International
| Japan | 4 |
Operativ
| Director/Board Member | 3 |
| Founder | 1 |
| President | 1 |
Sektoral
| Health Technology | 2 |
| Commercial Services | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| WELBE, INC. | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
| Welbe Healthcare, Inc. | Health Services |
- Börse
- Insiders
- Makoto Ota
- Erfahrung
